Examining the Impact of an Online, Non-restrictive Diet Among Persons
Examining the Impact of an Online, Non-restrictive Diet Among Persons With Multiple Sclerosis
What it found
A paper reports the results; we have not read it yet. See Papers below.
What was tested
Treatment tested
- 800g Challenge
What it measured
Main measures
Metabolic Health
From recruitment to end of 8 week intervention
Body Weight
From recruitment to end of 8 week intervention
Body Fat
From recruitment to end of 8 week intervention
Other measures (5)
6-Minute Walk
From recruitment to end of 8 week intervention
Walking and mobility25-Foot Walk
From recruitment to end of 8 week intervention
Walking and mobilityCognitive Assessments
From recruitment to end of 8 week intervention
Thinking and memoryFatigue
From recruitment to end of 8 week intervention
FatigueHealth-Related Quality of Life
From recruitment to end of 8 week intervention
Quality of life (reported by participants)
Who could take part
MS (type not specified) · 18 to 70
Show the full criteria
Inclusion criteria
* age 18-70 years * a self-reported diagnosis of multiple sclerosis * relapse free in past 30 days * non-pregnant * willing and able to visit University of North Texas on two testing occasions
Exclusion criteria
* electronic medical implant, such as a heart pacemaker or an implantable cardioverter defibrillator (ICD)
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
The current study aims to test an online, non-restrictive diet among persons with multiple sclerosis (MS). Diet is the number one searched second-line therapy among persons with MS, however there are currently no established dietary approaches to improve health and wellbeing among persons with MS. Participants will complete the 8-week diet program using an online application. The primary research question is whether the diet program is acceptable and can improve general health indicators including cholesterol, glucose, body weight, body fat as well as MS symptoms (i.e., walking, cognition, fatigue, and quality of life).
Papers
Loading reviews and guidelines…
History
Started
Jan 2023
Main results due
Apr 2023
Finished
Apr 2023